Choice of Acid Suppressant Therapy and Long ‐Term Graft Outcomes after Kidney Transplantation

ConclusionThere was no difference in renal function, rejection, or graft loss between PPI and H2RA treated patients. The majority of patients were maintained on PPI therapy for several years post ‐transplant without a clear indication; critical evaluation of ongoing need for acid suppressant therapy in the post‐transplant course should be an area of future focus.

https://onlinelibrary.wiley.com/doi/abs/10.1002/phar.2470?af=R

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - October 9, 2020 Category: Drugs & Pharmacology Authors: Spenser E. January, Kristin Progar, Nicole M. Nesselhauf, Jennifer C. Hagopian, Andrew F. Malone Tags: ORIGINAL RESEARCH ARTICLE Source Type: research